Is Buffett Right about Teva? — Market Mad House

One of Warren Buffett’s oddest stock holdings is the Israeli/American drug maker Teva Pharmaceutical Industries Ltd (NYSE: TEVA).

Teva is cheap; trading at $13.30 a share on 20 February 2020. However, Teva’s revenue growth, and gross profit are shrinking.

Teva’s quarterly gross profit fell from $1.977 billion on 30 September 2018 to $1.829 billion a year later. Between September 2018 and September 2019, Teva suffered four quarters of revenue growth shrinkage.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Daniel G. Jennings

Daniel G. Jennings is a writer who lives and works in Colorado. He is a lifelong history buff who is fascinated by stocks, politics, and cryptocurrency.